Literature DB >> 28699821

Physical activity in patients with COPD: the impact of comorbidities.

Leandro Cruz Mantoani1, Silvina Dell'Era1,2, William MacNee1, Roberto A Rabinovich1.   

Abstract

INTRODUCTION: Comorbidities are common in patients with chronic obstructive pulmonary disease (COPD) and it plays an important role on physical activity (PA) in this population. Since low PA levels have been described as a key factor to predict morbi-mortality in COPD, it seems crucial to review the current literature available on this topic. Areas covered: This review covers the most common comorbidities found in COPD, their prevalence and prognostic implications. We explore the differences in PA between COPD patients with and without comorbidities, as well as the impact of the number or type of comorbidities on activity levels of this population. The effect of different comorbidities on activities of daily living in patients with COPD is also reviewed. Finally, we discuss options for the treatment of inactivity in COPD patients considering their comorbidities and limitations. Expert commentary: Comorbidities are highly prevalent in patients with COPD and further deteriorate PA levels in this population. Despite the wide range of interventions available in COPD, the evidence in the field seems to point at PA coaching with feedback on individual goals and longer lasting PR programmes with more than 12 weeks of duration when attempting to raise the activity levels of this population.

Entities:  

Keywords:  COPD; comorbidity; physical activity; sedentary lifestyle

Mesh:

Year:  2017        PMID: 28699821     DOI: 10.1080/17476348.2017.1354699

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  8 in total

1.  Identification of Phenotypes in People with COPD: Influence of Physical Activity, Sedentary Behaviour, Body Composition and Skeletal Muscle Strength.

Authors:  Rafaella F Xavier; Ana Carolina A C Pereira; Aline C Lopes; Vinícius Cavalheri; Regina M C Pinto; Alberto Cukier; Ercy M C Ramos; Celso R F Carvalho
Journal:  Lung       Date:  2018-11-14       Impact factor: 2.584

2.  Efficacy of tiotropium bromide combined with different doses of fluticasone plus salmeterol DPI in the treatment of stable COPD.

Authors:  Xiao Ma; Jingjing Xu; Jun Yang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry.

Authors:  Wilson D Pace; Elias Brandt; Victoria A Carter; Ku-Lang Chang; Chelsea L Edwards; Alexander Evans; Chester Fox; Gabriela Gaona; MeiLan K Han; Alan G Kaplan; Rachel Kent; Janwillem W H Kocks; Maja Kruszyk; Chantal E Le Lievre; Tessa Li Voti; Cathy Mahle; Barry Make; Amanda R Ratigan; Asif Shaikh; Neil Skolnik; Brooklyn Stanley; Barbara P Yawn; David B Price
Journal:  Ann Fam Med       Date:  2022 Jul-Aug       Impact factor: 5.707

4.  Medical history, medication use and physical activity in adults in their eighth and ninth decade of life in the Hertfordshire Cohort Study.

Authors:  Gregorio Bevilacqua; Jean Zhang; Camille Parsons; Faidra Laskou; Nicholas Fuggle; Cyrus Cooper; Elaine Dennison
Journal:  EXCLI J       Date:  2022-04-19       Impact factor: 4.022

5.  The association between accelerometer-assessed physical activity and respiratory function in older adults differs between smokers and non-smokers.

Authors:  Mohamed Amine Benadjaoud; Mehdi Menai; Vincent T van Hees; Vadim Zipunnikov; Jean-Philippe Regnaux; Mika Kivimäki; Archana Singh-Manoux; Séverine Sabia
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

Review 6.  Effects of Resistance Exercise on Cerebral Redox Regulation and Cognition: An Interplay Between Muscle and Brain.

Authors:  Ricardo A Pinho; Aderbal S Aguiar; Zsolt Radák
Journal:  Antioxidants (Basel)       Date:  2019-11-06

Review 7.  Computed tomography-based body composition measures in COPD and their association with clinical outcomes: A systematic review.

Authors:  John M Nicholson; Camila E Orsso; Sahar Nourouzpour; Brenawen Elangeswaran; Karan Chohan; Ani Orchanian-Cheff; Lee Fidler; Sunita Mathur; Dmitry Rozenberg
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

Review 8.  Personalized medicine for patients with COPD: where are we?

Authors:  Frits Me Franssen; Peter Alter; Nadav Bar; Birke J Benedikter; Stella Iurato; Dieter Maier; Michael Maxheim; Fabienne K Roessler; Martijn A Spruit; Claus F Vogelmeier; Emiel Fm Wouters; Bernd Schmeck
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.